Want to see VAXX full AI Analyst Report?
Vaxxinity Inc (VAXX) Financial Statements
Vaxxinity Inc Financial Overview
Vaxxinity Inc's market cap is currently $14.07K. The company's EPS TTM is $-0.45; its P/E ratio is -0.20; Vaxxinity Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 66.00K | $ 557.00K | $ 0.00 |
| Gross Profit | $ -2.23M | $ -1.68M | $ -1.87M | $ 505.00K | $ -107.00K |
| Operating Income | $ -58.28M | $ -75.98M | $ -125.08M | $ -32.28M | $ -13.66M |
| EBITDA | $ -54.00M | $ -73.02M | $ -135.23M | $ -38.06M | $ -13.58M |
| Net Income | $ -56.93K | $ -75.21M | $ -137.18M | $ -39.96M | $ -14.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 30.39M | $ 86.83M | $ 144.88M | $ 31.14M | $ 476.00K |
| Total Assets | $ 44.31M | $ 106.40M | $ 166.67M | $ 50.14M | $ 1.59M |
| Total Debt | $ 15.17M | $ 14.55M | $ 10.70M | $ 38.30M | $ 14.33M |
| Net Debt | $ 10.24M | $ -18.93M | $ -134.19M | $ 7.16M | $ 13.86M |
| Total Liabilities | $ 30.90M | $ 44.22M | $ 38.05M | $ 137.52M | $ 50.11M |
| Stockholders' Equity | $ 13.41M | $ 62.18M | $ 128.62M | $ -87.38M | $ -48.51M |
| Cash Flow | |||||
| Free Cash Flow | $ -58.04M | $ -57.79M | $ -82.31M | $ -35.39M | $ -12.27M |
| Operating Cash Flow | $ -57.24M | $ -55.93M | $ -80.99M | $ -33.91M | $ -12.27M |
| Investing Cash Flow | $ 28.84M | $ -54.39M | $ -1.32M | $ -1.48M | $ 0.00 |
| Financing Cash Flow | $ -1.14M | $ -167.00K | $ 196.17M | $ 66.11M | $ 11.14M |
Currency in USD
